BlackRock Group’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1M Sell
27,703
-7,952
-22% -$302K ﹤0.01% 2134
2016
Q3
$1.52M Buy
35,655
+559
+2% +$24.9K ﹤0.01% 1799
2016
Q2
$1.49M Sell
35,096
-186
-0.5% -$8.09K ﹤0.01% 1737
2016
Q1
$1.47M Sell
35,282
-4,783
-12% -$188K ﹤0.01% 1716
2015
Q4
$1.57M Sell
40,065
-905
-2% -$33.8K ﹤0.01% 1621
2015
Q3
$1.38M Sell
40,970
-211
-0.5% -$7.51K ﹤0.01% 1702
2015
Q2
$1.36M Buy
41,181
+2,268
+6% +$78K ﹤0.01% 1769
2015
Q1
$1.4M Buy
38,913
+1,426
+4% +$44.8K ﹤0.01% 1672
2014
Q4
$1.13M Buy
37,487
+19,897
+113% +$583K ﹤0.01% 1811
2014
Q3
$544K Buy
17,590
+1,072
+6% +$35.6K ﹤0.01% 2137
2014
Q2
$598K Sell
16,518
-13,621
-45% -$440K ﹤0.01% 2126
2014
Q1
$908K Buy
30,139
+3,760
+14% +$86.7K ﹤0.01% 2031
2013
Q4
$602K Sell
26,379
-16,715
-39% -$349K ﹤0.01% 2163
2013
Q3
$896K Buy
43,094
+19,144
+80% +$465K ﹤0.01% 1969
2013
Q2
$644K Buy
+23,950
New +$717K ﹤0.01% 1979

Other funds holding OFIX

BlackRock Group's OFIX Position: Q4 2016 in Review

BlackRock Group reduced its Orthofix Medical (OFIX) stake by 22% in Q4 2016, selling an estimated $302K and leaving 27,703 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

BlackRock Group first reported a position in OFIX in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.57M in Q4 2015. 136 funds tracked by Wall St. Rank hold OFIX as of Q4 2016.

  • BlackRock Group held 27,703 shares of Orthofix Medical worth $1M as of Q4 2016.
  • BlackRock Group sold 7,952 Orthofix Medical shares in Q4 2016, an estimated $302K.
  • Orthofix Medical made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2134 holding.
  • BlackRock Group first reported a position in Orthofix Medical in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Orthofix Medical position peaked at $1.57M in Q4 2015.
  • 136 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.